A new MRI method measures cardiac oxygen use in three minutes without catheters or radiation, offering a simpler way to study ...

Your smartwatch might be watching out for your heart—but it can’t tell you everything. Learn what wearable health alerts ...

HeartBeam (NASDAQ: BEAT), a medical technology company focused on transforming cardiac care through personalized ...

One of the most widely used diagnostic tools in cardiology is the ECG machine, a device that records the electrical activity ...

Warfarin is an oral anticoagulant, commonly known as blood thinner, that is prescribed to help treat the formation of ...

The research found that men in their mid-30s have nearly double the risk of developing cardiovascular disease within the next ...

Detailed price information for Irhythm Holdings Inc (IRTC-Q) from The Globe and Mail including charting and trades.

The American Academy of Neurology (AAN) unveiled new guidelines regarding the use of wearable devices, such as smart watches and fitness trackers, in a March article published in Neurology. Among the ...

Brian Humbarger, our new Chief Commercial Officer, will provide an overview of our limited commercial launch. Before we dive ...

ADHD medications—especially stimulants—can raise your blood pressure and heart rate. Other factors that can increase your risk of cardiovascular disease, like sleep problems, substance use, and excess ...

HeartBeam and Mount Sinai Announce Strategic AI Collaboration to Bring Clinical-Grade Heart Monitoring into the Home ...

HeartBeam's collaboration with Mount Sinai aims to accelerate AI-ECG algorithm development using 3D ECG technology and clinical datasets to enhance remote cardiac monitoring and preventive cardiology.